MedPath

Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: An innovative strategy including a computerised decision support system compared to a common strategy of professional audit and feedback

Conditions
Pre-eclampsiaPregnancyGestational hypertensionImplementationGuidelinesComputerized decision support systemCost-effectivenessImplementatie, richtlijnen, pre-eclampsie, pre-existente hypertensie, zwangerschap, zwanherschapshypertensie
Registration Number
NL-OMON28902
Lead Sponsor
ZonMw
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1. Pregnant women who develop severe hypertension or preeclampsia

Exclusion Criteria

1. Refusal to participate

2. Diagnosis of lethal fetal congenital abnormalities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure for the evaluation of the effectiveness of both strategies is a combined rate of major maternal complications (maternal death, organ specific complications of hypertension, HELLP syndrome, placental abruption)
Secondary Outcome Measures
NameTimeMethod
- Guidelines' adherence rates <br /><br>- Fetal death rates<br /><br>- Caesarean delivery rates<br /><br>- Rates of neonatal mortality and morbidity <br /><br>- Experiences with the implementaion strategies. (participation etc)<br />
© Copyright 2025. All Rights Reserved by MedPath